KaydedilenlerDerginizi ekleyin

Dergiler / Balkan Medical Journal / 2018 / Cilt: 35 - Sayı: 3

The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg Paradox

Flora ÖZKALAYCI
Armağan ALTUN
Betül UĞUR ALTUN
Seithikurippu Ratnas PANDİ PERUMAL
Öykü GÜLMEZ
Sayfa
225–232
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The aim of this review is to discuss the currentknowledge and the role of osteoprotegerin in cardiovascular disease.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Cardiovascular disease is one of the most frequent causes of mortalityand morbidity worldwide.
📊
Temel Bulgular & Veri:Several variables have been identified asrisk factors for cardiovascular disease.
💡
Sonuç & Katkı:The aim of this review is to discuss the currentknowledge and the role of osteoprotegerin in cardiovascular disease.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Cardiovascular disease is one of the most frequent causes of mortalityand morbidity worldwide. Several variables have been identified asrisk factors for cardiovascular disease. Recently, the role of receptoractivator of nuclear factor kappa B, receptor activator of nuclear factorkappa B ligand, and the osteoprotegerin system has been recognized asmore important in the pathogenesis of cardiovascular disease. Besidestheir roles in the regulation of bone resorption, these moleculeshave been reported to be associated with the pathophysiology ofcardiovascular disease. There are conflicting data regarding theimpact of osteoprotegerin, a glycoprotein with a regulatory role in thecardiovascular system. The aim of this review is to discuss the currentknowledge and the role of osteoprotegerin in cardiovascular disease.

🔖

Bu Makaleye Atıf Yap

ÖZKALAYCI, F., ALTUN, A., ALTUN, B. U., PERUMAL, S. R. P., GÜLMEZ, Ö. (2022). The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg Paradox. Balkan Medical Journal, Cilt: 35 - Sayı: 3, 225–232. https://ajindex.com/articles/461080

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Mankoc-Ramus S, Kumse T, Globocnik Petrovic M, Petrovic D, Cilensek I. SNP rs 2073618 of the osteoprotegerin gene is associated with diabetic retinopathy in Slovenian patients with type 2 diabetes. Bio Med Res Int 2013;2013:364073. Perez de Ciriza C, Lawrie A, Varo N. Influence of preanalytical and analytical factors on osteoprotegerin measurments. Clin Biochem 2014:47:1279-85.
  2. Michowitz Y, Goldstem E, Roth A, Afek A, Abashidze, Ben Gal Y, et al. The involvement of tumor necrosis factor related apoptosis-inducing ligand (TRAIL) in atherosclerosis. J Am Coll Cardiol 2005;45:1018-24.
  3. Seccihiero P, Candido R, Corallini F, Zacchigna S, Toffoli B, Rimondi E, et al. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice. Circulation 2006;114:1522-30.
  4. Kim HH, Shin HS, Kwak HJ, Ahn KY, Kim JH, Lee MS, et al. RANKL regulates endothelial cell survival through the phosphatidylinositol 3-kinase/Akt signal transduction pathway. FASEB J 2003;17:2163-5.
  5. Kim YM, Kim YM, Lee YM, Kim HS, Kim JD, Choi Y, et al. TNF-related activationinduced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells. J Biol Chem 2002;277:6799-805.
  6. Min JK, Kim YM, Kim YM, Kim EC, Gho YS, Kang IJ, et al. Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand. J Biol Chem 2003;278:39548-57.
  7. Shaker OG, El-Shehaby A, Nabih M. Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease. Angiology 2010;61:756-62. Safar ME, ‎Edward D. Frohlich. Large Arteries and Cardiovascular Risk. Atherosclerosis, Press; 2007:44:117-24.
  8. Lakatta EG, Mitchell JH, Pomerance A, Rowe GG. Human aging: changes in structure and function. J Am Coll Cardiol 1987;(2 Suppl A)10:42-7.
  9. Proudfoot D, Shanahan CM. Biology of calcification in vascular cells: intima versus media. Herz 2001;26:245-51.
  10. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Boström K, et al. Multilineage potential of cells from the artery wall. Circulation 2003;108:2505-10.
  11. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004;24:1161-70.
  12. Hosbond SE, Poulsen TS, Diederichsen AC, Nybo M, Rasmussen LM, Mickley H.